Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
Australia
Scientia Clinical Research Ltd, Sydney, New South Wales Doherty Clinical Trials, East Melbourne, Victoria Nucleus Network, Melbourne, Victoria